Earnings Ahead

ILMN - Illumina

183.43 -8.45 -4.4

Illumina

Illumina

About

Profile

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ILMN

The life science stock popped 3.5% after a European Union court advisor said regulators exceeded their power in blocking Illuminas bid for health care company Grail.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Illumina rises as Carl Icahn sees positives in CEO transition (update)
  • Illumina CEO Francis deSouza resigns
  • House Republicans seek information from FTC over Illumina's Grail deal
  • Illumina unit Grail in hot water over erroneous cancer results – FT
  • Illumina names Hologic CEO as chair, elects Edwards CFO to board
  • Illumina launches AI software to predict disease-causing genetic mutations
  • Illumina stock declines as shareholder voting results overdone - Evercore
  • Icahn holdings Illumina, CVR Energy drop amid Icahn Enterprises' weakness
  • Illumina chairman out, CEO survives, one Icahn nominee elected
  • Illumina director says company prepared if CEO, chairman tossed out - FT
  • Carl Icahn adds Illumina in Q1, cuts stakes in Herc, Newell Brands
  • Illumina board tells shareholders to ignore Carl Icahn's 'unfit associates'
  • Illumina wins partial victory in Icahn battle as proxy firm ISS backs CEO DeSouza
  • Glass Lewis backs Carl Icahn attempt to replace Illumina CEO and chair
  • Carl Icahn urges Illumina to divest GRAIL as soon as possible
  • Illumina DNA sequencing devices could be vulnerable to hackers - FDA
  • Illumina unveils $100M annual cost cutting plan
  • Illumina Non-GAAP EPS of $0.08 beats by $0.05, revenue of $1.09B beats by $20M
  • Illumina under the spotlight as Q1 earnings approach
  • Carl Icahn further accuses Illumina board of 'obfuscation'

Earnings History

Date EPS / Forecast Revenue / Forecast
February 10, 2022 0.75 / 0.4562 1.2B / 1.13B Beat!
November 4, 2021 1.45 / 1.31 1.11B / 1.05B Beat!
August 5, 2021 1.87 / 1.36 1.13B / 1.02B Beat!
April 27, 2021 1.89 / 1.39 1.09B / 996.34M
February 11, 2021 1.22 / 1.11 953M / 903.91M Beat!
January 27, 2021 - / 1.42 - / 870.51M
October 29, 2020 1.02 / 0.813 794M / 715.83M Beat!
August 6, 2020 0.62 / 0.67 633M / 679.55M
April 30, 2020 1.64 / 1.26 859M / 853.91M Beat!
January 29, 2020 1.7 / 1.58 953M / 942.43M Beat!
October 24, 2019 1.93 / 1.4 907M / 870.9M Beat!
July 29, 2019 1.35 / 1.34 838M / 855.87M
April 25, 2019 1.6 / 1.34 846M / 834.28M Beat!
January 29, 2019 1.32 / 1.36 867M / 862.81M Beat!
October 23, 2018 1.52 / 1.26 853M / 828.24M Beat!
July 30, 2018 1.43 / 1.11 830M / 787.43M Beat!
April 24, 2018 1.45 / 1.02 782M / 744.3M Beat!
January 30, 2018 1.44 / 1.22 714.0M / 750.24M
October 24, 2017 1.11 / 0.99 662.0M / 692.84M
August 1, 2017 0.82 / 0.69 598.0M / 642.36M
April 25, 2017 0.64 / 0.64 598M / 590.75M Beat!
Date Price Open High Low Vol Change
Apr 18 116.66 116.25
119.11
115.73
1.6M -1.34%
Apr 17 118.25 117.86
120.06
117.42
1.6M 0.48%
Apr 16 117.69 119.2
119.48
116.89
1.7M -2.86%
Apr 15 121.16 119.2
128.28
120.97
-4.65%
Apr 12 127.07 129
134.85
126.44
1.6M -2.78%
 
Apr 11 130.7 132.07
133.21
128.08
1.1M -0.36%
Apr 10 131.17 128.9
132.34
128.24
1.9M -1.8%
Apr 9 133.57 131.56
135.26
130.73
1.7M 2.65%
Apr 8 130.12 128.09
130.55
127.3
1.1M 1.86%
Apr 5 127.75 125.05
129.56
123.66
1.1M 1.39%
Apr 4 126 129.82
131.49
125.87
2.7M -1.36%
Apr 3 127.74 127.2
130.09
127
1.9M -0.61%
Apr 2 128.52 131.16
131.8
128.27
2.0M -3.16%
Apr 1 132.72 138.16
138.53
131.32
1.2M -3.35%
Mar 28 137.32 138.68
140.07
136.29
917K -0.98%
Mar 27 138.68 135.51
138.68
134.47
952K 3.65%
Mar 26 133.8 134.43
135.86
133.44
1.1M -0.19%
Mar 25 134.06 137.24
137.53
132.77
967K -2.32%
Mar 22 137.24 137.02
137.49
133.87
1.3M -0.15%
Mar 21 137.45 140.71
144.19
136.42
2.0M 3.20%
Mar 20 133.19 132.68
133.29
129.75
1.2M 0.02%
Mar 19 133.16 128.88
135.81
128.49
3.0M 2.32%
Mar 18 130.14 128.38
131.58
125.82
2.8M 1.89%
Mar 15 127.73 127.5
128.55
126.28
2.2M -0.29%
Mar 14 128.1 131.94
133.2
126.2
1.4M -3.52%
Mar 13 132.78 132
135.61
131.6
1.6M 0.05%
Mar 12 132.71 138.94
138.94
132.62
2.1M -4.57%
Mar 11 139.06 136.3
140.22
135.52
1.3M 2.68%
Mar 8 135.43 137.23
139.84
134.28
1.9M -0.42%
Mar 7 136 136.82
138.77
135.3
1.1M 0.64%
Mar 6 135.13 136.31
137.19
133.38
1.2M 0.33%
Mar 5 134.68 136.2
137.39
134.42
1.2M -2.19%
Mar 4 137.7 140.25
140.8
135.92
1.1M -1.99%
Mar 1 140.5 139.2
142.7
135.47
1.9M 0.48%
Feb 29 139.83 143.97
146.08
139.78
1.2M -0.82%
Feb 28 140.98 138.32
143.17
138.12
1.2M 0.87%
Feb 27 139.76 137.03
140.05
134.79
1.3M 2.04%
Feb 26 136.97 135.01
139.66
135
2.0M 2.98%
Feb 23 133 135.77
136.61
132.91
1.3M -1.88%
Feb 22 135.55 137.34
137.41
134.15
2.1M -0.63%
Feb 21 136.41 137.5
139.14
133.87
1.5M -2.6%
Feb 20 140.05 141.72
142.9
138.6
1.3M -2.34%
Feb 16 143.41 144.17
147.25
142.7
1.9M -1.82%
Feb 15 146.07 142.17
147
141
1.3M 3.79%
Feb 14 140.74 135.02
140.95
134.02
1.7M 5.23%
Feb 13 133.74 136.49
137.96
129.63
2.3M -4.44%
Feb 12 139.96 137.84
140.32
135.31
2.5M 1.54%
Feb 9 137.84 143.75
147.7
135.3
3.7M -3.83%
Feb 8 143.33 142.47
144.85
139.19
2.4M 0.27%
Feb 7 142.94 145.09
145.09
139.91
1.7M -1.35%
Feb 6 144.89 142.1
146.12
141.21
1.8M 1.87%
Feb 5 142.23 142.9
143.27
141.34
1.3M -1.37%
Feb 2 144.21 143.87
145.04
141.56
1.2M -1.05%
Feb 1 145.74 143.69
145.93
143
1.6M 1.91%
Jan 31 143.01 146.48
148.19
142.46
2.0M -2.85%
Jan 30 147.2 144.66
147.95
144.66
1.4M 0.33%
Jan 29 146.72 140.97
146.88
139.37
1.4M 4.33%
Jan 26 140.63 145.17
145.47
140.14
2.0M -1.49%
Jan 25 142.76 143.69
144.82
139.63
1.4M 1.24%
Jan 24 141.01 142.5
142.5
139.9
2.1M 0%